HK52297A - New process for preparing formoterol and related compounds - Google Patents

New process for preparing formoterol and related compounds Download PDF

Info

Publication number
HK52297A
HK52297A HK52297A HK52297A HK52297A HK 52297 A HK52297 A HK 52297A HK 52297 A HK52297 A HK 52297A HK 52297 A HK52297 A HK 52297A HK 52297 A HK52297 A HK 52297A
Authority
HK
Hong Kong
Prior art keywords
compound
process according
fumarate
carbon atoms
straight
Prior art date
Application number
HK52297A
Other languages
German (de)
English (en)
French (fr)
Inventor
William Trofast Jan
Jakupovic Edib
Katarina M Nsson Lena
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HK52297A publication Critical patent/HK52297A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
HK52297A 1990-09-26 1997-04-24 New process for preparing formoterol and related compounds HK52297A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process
PCT/SE1991/000643 WO1992005147A1 (en) 1990-09-26 1991-09-25 New process for preparing formoterol and related compounds

Publications (1)

Publication Number Publication Date
HK52297A true HK52297A (en) 1997-05-02

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
HK52297A HK52297A (en) 1990-09-26 1997-04-24 New process for preparing formoterol and related compounds

Country Status (28)

Country Link
EP (1) EP0550612B1 (cs)
JP (1) JP2801401B2 (cs)
KR (1) KR0179639B1 (cs)
AT (1) ATE134990T1 (cs)
AU (1) AU652386B2 (cs)
BG (1) BG61605B1 (cs)
CA (1) CA2091343C (cs)
CZ (1) CZ284256B6 (cs)
DE (1) DE69117768T2 (cs)
DK (1) DK0550612T3 (cs)
EE (1) EE02979B1 (cs)
ES (1) ES2084831T3 (cs)
FI (1) FI111714B (cs)
GR (1) GR3020134T3 (cs)
HK (1) HK52297A (cs)
HU (1) HU214054B (cs)
IE (1) IE74387B1 (cs)
IS (1) IS1684B (cs)
LT (1) LT3813B (cs)
LV (1) LV10770B (cs)
NO (1) NO301709B1 (cs)
PL (1) PL166434B1 (cs)
PT (1) PT99051B (cs)
RU (1) RU2079486C1 (cs)
SE (1) SE9003057D0 (cs)
SG (1) SG43150A1 (cs)
SK (1) SK22793A3 (cs)
WO (1) WO1992005147A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) * 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
CA2271004C (en) * 1996-11-11 2007-05-01 Sepracor Inc. Process for the preparation of optically pure isomers of formoterol
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
DE10290563D2 (de) * 2001-02-22 2004-04-29 Universitaetsklinikum Charite Mittel zur Hemmung von Tumorzellen
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
AU2008320590A1 (en) * 2007-10-29 2009-05-07 Generics [Uk] Limited Novel chromatography methods
JP4837800B2 (ja) 2008-05-13 2011-12-14 アストラゼネカ・アクチエボラーグ ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250B (zh) * 2022-09-02 2024-07-26 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法
CN117682969A (zh) * 2023-07-31 2024-03-12 浙江理工大学 一种福莫特罗中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2366625C2 (cs) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
CZ44293A3 (en) 1994-01-19
HU214054B (en) 1997-12-29
FI931333A0 (fi) 1993-03-25
EE02979B1 (et) 1997-04-15
PL166434B1 (pl) 1995-05-31
FI111714B (fi) 2003-09-15
SK22793A3 (en) 1993-07-07
LT3813B (en) 1996-03-25
NO931058L (no) 1993-03-23
LTIP1715A (en) 1995-07-25
EP0550612B1 (en) 1996-03-06
NO931058D0 (no) 1993-03-23
IE74387B1 (en) 1997-07-30
ES2084831T3 (es) 1996-05-16
GR3020134T3 (en) 1996-08-31
NO301709B1 (no) 1997-12-01
EP0550612A1 (en) 1993-07-14
AU8652091A (en) 1992-04-15
HUT65912A (en) 1994-07-28
SE9003057D0 (sv) 1990-09-26
DE69117768T2 (de) 1996-08-29
JP2801401B2 (ja) 1998-09-21
WO1992005147A1 (en) 1992-04-02
IS3756A7 (is) 1992-03-27
IS1684B (is) 1998-02-24
CA2091343A1 (en) 1992-03-27
LV10770B (en) 1996-04-20
BG61605B1 (bg) 1998-01-30
JPH06501262A (ja) 1994-02-10
KR0179639B1 (ko) 1999-05-15
FI931333L (fi) 1993-04-22
LV10770A (lv) 1995-08-20
DK0550612T3 (da) 1996-07-22
DE69117768D1 (de) 1996-04-11
IE913373A1 (en) 1992-04-08
CA2091343C (en) 2002-07-09
HU9300867D0 (en) 1993-06-28
PT99051A (pt) 1992-08-31
RU2079486C1 (ru) 1997-05-20
ATE134990T1 (de) 1996-03-15
SG43150A1 (en) 1997-10-17
AU652386B2 (en) 1994-08-25
BG97576A (bg) 1994-03-31
CZ284256B6 (cs) 1998-10-14
PT99051B (pt) 1999-02-26

Similar Documents

Publication Publication Date Title
EP0550612B1 (en) New process for preparing formoterol and related compounds
US5434304A (en) Process for preparing formoterol and related compounds
US5545745A (en) Enantioselective preparation of optically pure albuterol
KR960003810B1 (ko) 광학적 활성 벤젠 설폰아미드 유도체의 제조방법
SK283591B6 (sk) Spôsob prípravy tolterodínu a medziprodukt
EP0391070B1 (en) Process for the preparation of N-methyl-3-(p-trifluoro-methylphenoxy)-3-phenyl-propylamine and their salts
FI62528B (fi) Ett nytt foerfarande foer framstaellning av 1-(3,5-dihydroxifenyl)-1-hydroxi-2-(1-metyl-2-(4-hydroxifenyl)-etyl)-aminoetan
US4336268A (en) Cyclohexene derivative analgesics
WO2007144097A1 (en) New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
EP0420120B1 (en) Optically active benzyl alcohol compound and pharmaceutical composition
HU177107B (en) Process for producing new 1-phenyl-ethanolamine derivatives of antyflogistic activity
HU195204B (en) Process for the diastereoselective reduction of 3-amino-1-benzoxepin-5/2/+/-ones
EP0101633B1 (en) Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
KR800000537B1 (ko) 아미노-페닐-에탄올아민의 제조방법
GB2067195A (en) 2-aminomethyl-6-halo-phenols their production and pharmaceutical composition containing them
KR800000539B1 (ko) 아미노-페닐-에탄올아민의 제조방법
PL82685B1 (en) Dibenzazepine derivatives and their preparation[ie34441b1]
CS247575B1 (cs) Deriváty 1-fenoxy-3-fenoxyethylamino-2-propanolu a způsob jejich přípravy
HU207308B (en) Process for producing 1- /2-/5-/dimethyl-amino-methyl/-2-/furyl-methyl-thio/-ethyl//- -amino-1-/methyl-amino-2-nitro-ethylene

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110924